Literature DB >> 25761974

Assessing Susceptibility to Epilepsy in Three Rat Strains Using Brain Metabolic Profiling Based on HRMAS NMR Spectroscopy and Chemometrics.

Florence Fauvelle1,2,3,4,5, Julien Boccard6, Fanny Cavarec5,7, Antoine Depaulis5,7,8, Colin Deransart5,7,8.   

Abstract

The possibility that a metabolomic approach can inform about the pathophysiology of a given form of epilepsy was addressed. Using chemometric analyses of HRMAS NMR data, we compared several brain structures in three rat strains with different susceptibilities to absence epilepsy: Genetic Absence Epilepsy Rats from Strasbourg (GAERS), Non Epileptic Control rats (NEC), and Wistar rats. Two ages were investigated: 14 days postnatal (P14) before the onset of seizures and 5 month old adults with fully developed seizures (Adults). The relative concentrations of 19 metabolites were assessed using (1)H HRMAS NMR experiments. Univariate and multivariate analyses including multiblock models were used to identify the most discriminant metabolites. A strain-dependent evolution of glutamate, glutamine, scyllo-inositol, alanine, and glutathione was highlighted during cerebral maturation. In Adults, data from somatosensory and motor cortices allowed discrimination between GAERS and NEC rats with higher levels of scyllo-inositol, taurine, and phosphoethanolamine in NEC. This epileptic metabolic phenotype was in accordance with current pathophysiological hypothesis of absence epilepsy (i.e., seizure-generating and control networks) and putative resistance of NEC rats and was observed before seizure onset. This methodology could be very efficient in a clinical context.

Entities:  

Keywords:  absence epilepsy; consensus OPLS-DA; metabolomics; multiblock model; multivariate statistical analysis; rat models

Mesh:

Substances:

Year:  2015        PMID: 25761974     DOI: 10.1021/pr501309b

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats.

Authors:  Philippe De Deurwaerdère; Maurizio Casarrubea; Daniel Cassar; Manuela Radic; Emilie Puginier; Abdeslam Chagraoui; Giuseppe Crescimanno; Vincenzo Crunelli; Giuseppe Di Giovanni
Journal:  Front Cell Neurosci       Date:  2022-05-23       Impact factor: 6.147

2.  Altered lipid metabolism in post-traumatic epileptic rat model: one proposed pathway.

Authors:  Niraj Kumar Srivastava; Somnath Mukherjee; Rajkumar Sharma; Jharana Das; Rohan Sharma; Vikas Kumar; Neeraj Sinha; Deepak Sharma
Journal:  Mol Biol Rep       Date:  2019-01-31       Impact factor: 2.316

Review 3.  Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review.

Authors:  Wanlin Lai; Dan Du; Lei Chen
Journal:  Neurochem Res       Date:  2022-01-24       Impact factor: 3.996

4.  Metabolomics As a Tool for the Characterization of Drug-Resistant Epilepsy.

Authors:  Federica Murgia; Antonella Muroni; Monica Puligheddu; Lorenzo Polizzi; Luigi Barberini; Gianni Orofino; Paolo Solla; Simone Poddighe; Francesco Del Carratore; Julian L Griffin; Luigi Atzori; Francesco Marrosu
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

5.  Brain Metabolic Changes in Rats following Acoustic Trauma.

Authors:  Jun He; Yejin Zhu; Jiye Aa; Paul F Smith; Dirk De Ridder; Guangji Wang; Yiwen Zheng
Journal:  Front Neurosci       Date:  2017-03-24       Impact factor: 4.677

6.  A metabolic biomarker predicts Parkinson's disease at the early stages in patients and animal models.

Authors:  David Mallet; Thibault Dufourd; Mélina Decourt; Carole Carcenac; Paola Bossù; Laure Verlin; Pierre-Olivier Fernagut; Marianne Benoit-Marand; Gianfranco Spalletta; Emmanuel L Barbier; Sebastien Carnicella; Véronique Sgambato; Florence Fauvelle; Sabrina Boulet
Journal:  J Clin Invest       Date:  2022-02-15       Impact factor: 14.808

7.  Developmental changes of GABA immunoreactivity in cortico-thalamic networks of an absence seizure model.

Authors:  Cristiano Bombardi; Marcello Venzi; Vincenzo Crunelli; Giuseppe Di Giovanni
Journal:  Neuropharmacology       Date:  2018-02-19       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.